Meta AnalysisID 2603
谷胱甘肽治疗自闭症谱系障碍的有效性与安全性
CRD42019121629
What are the evidence for effectiveness and safety of glutathione in treating Autism Spectrum Disorder in studies of people with Autism Spectrum Disorder?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 2603
- Evidence Id
- 11161
- Core Evidence Id
- 11161
- Source Meta Analysis Id
- 2553
- Herb2 Meta Analysis Id
- HBMA002553
- Crd Id
- CRD42019121629
- Title
- The effectiveness and safety of glutathione in treating Autism Spectrum Disorder
- Review Question
- What are the evidence for effectiveness and safety of glutathione in treating Autism Spectrum Disorder in studies of people with Autism Spectrum Disorder?
- Study Type Included
- Only articles with original data excluding commentaries, reviews, and protocols of clinical trials. Conference abstracts are included.
- Condition Being Studied
- Autism Spectrum Disorder as defined by the DSM (the Diagnostic and Statistical Manual of Mental Disorders by the American Psychiatric Association) criteria at the time of the studies
- Participant
- Participants with autism spectrum disorder of any age and gender
- Animal
- Human Disease Modelled
- Intervention
- Administration of glutathione
- Comparator Control
- Information on any comparison/control group of a study will be included
- Main Outcome
- For effectiveness outcomes, we will report change in scores as a result of the treatment from the baseline to the last available follow-up on any of the screening or diagnostic measures for autism spectrum disorder from this list: (https://www.carautismroadmap.org/autism-spectrum-disorder-measures/). We will include any safety outcomes reported as events during the follow-up period. Measures of effect We will extract data on dosage, timing, an other characteristics of glutathione administration.
- Outcome Measure
- Additional Outcome
- Not applicable
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- Autism Spectrum Disorder; Child; Child Development Disorders, Pervasive; Glutathione; Humans
- Contact
- Vadim Dukhanin [email protected]
- Organisational Affiliation
- Johns Hopkins University
- Funding Source
- U.S. Food and Drug Administration (FDA)
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- United States of America
- Review Stage
- Review Ongoing
- First Submission Date
- 2019-01-09
- Registration Date
- 2019-04-16
- Anticipated Start Date
- 2018-09-01
- Anticipated Completion Date
- 2019-08-31
- Title Cn
- 谷胱甘肽治疗自闭症谱系障碍的有效性与安全性
- Title En
- The effectiveness and safety of glutathione in treating Autism Spectrum Disorder
- Bilingual Status
- complete